[HTML][HTML] The fatty acid–bile acid conjugate aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease
…, S Abu-Mouch, A Fich, E Sikuler, A Issachar… - Clinical …, 2014 - Elsevier
Background & Aims We investigated the effects of the fatty acid–bile acid conjugate 3β-arachidyl-amido,
7α-12α-dihydroxy, 5β-cholan-24-oic acid (Aramchol; Trima Israel …
7α-12α-dihydroxy, 5β-cholan-24-oic acid (Aramchol; Trima Israel …
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease
M Shechter, A Issachar, I Marai, N Koren-Morag… - International journal of …, 2009 - Elsevier
BACKGROUND: Endothelial dysfunction is considered an important prognostic factor in
atherosclerosis. The aim of this study was to detect the long-term association of peripheral …
atherosclerosis. The aim of this study was to detect the long-term association of peripheral …
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients
…, A Gorgen, H Muaddi, AD Aravinthan, A Issachar… - Journal of …, 2019 - Elsevier
Background & Aims Radiofrequency ablation (RFA) is an effective treatment for single
hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients …
hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients …
[HTML][HTML] An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study
…, JR Gossage, CR Weiss, MA Latif, A Issachar… - …, 2021 - ncbi.nlm.nih.gov
Hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) is a rare multisystem
vascular disorder that causes chronic gastrointestinal bleeding, epistaxis, and severe …
vascular disorder that causes chronic gastrointestinal bleeding, epistaxis, and severe …
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
…, Y Kundel, O Benjaminov, M Braun, A Issachar… - Radiation …, 2017 - Springer
Background and Purpose Stereotactic body radiotherapy (SBRT) is an emerging modality
for definitive treatment of Hepatocellular carcinoma (HCC). Materials and Methods This …
for definitive treatment of Hepatocellular carcinoma (HCC). Materials and Methods This …
[HTML][HTML] Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
N Peleg, A Issachar, OS Arbib, M Cohen-Naftaly… - JHEP Reports, 2019 - Elsevier
Background & Aims Liver steatosis may occur concomitantly in patients with chronic hepatitis
B infection (CHB) and is implicated in increased morbidity and mortality. Hepatitis B virus (…
B infection (CHB) and is implicated in increased morbidity and mortality. Hepatitis B virus (…
AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease
N Peleg, A Issachar, O Sneh-Arbib… - Digestive and Liver …, 2017 - Elsevier
Background & aims Liver fibrosis is the single most important prognostic factor in patients with
non-alcoholic fatty liver disease (NAFLD). The predictive value of the AST to Platelet Ratio …
non-alcoholic fatty liver disease (NAFLD). The predictive value of the AST to Platelet Ratio …
The impact of preexisting and post-transplant diabetes mellitus on outcomes following liver transplantation
…, AC Doyle, SV Venkatachalapathy, A Issachar… - …, 2019 - journals.lww.com
Background. Diabetes mellitus (DM) is said to adversely affect transplant outcomes. The
aim of this study was to investigate the impact of pre-existing and new-onset DM on liver …
aim of this study was to investigate the impact of pre-existing and new-onset DM on liver …
Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response
N Peleg, A Issachar, O Sneh Arbib… - Journal of viral …, 2019 - Wiley Online Library
Sustained virological response (SVR) results in reduced incidence of hepatocellular carcinoma
(HCC) and mortality among chronic hepatitis C (CHC) patients with advanced fibrosis. …
(HCC) and mortality among chronic hepatitis C (CHC) patients with advanced fibrosis. …
Randomised clinical trial: a phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis
…, D Hakimian, W Hazou, A Issachar… - Alimentary …, 2021 - Wiley Online Library
Background Namodenoson, an A3 adenosine receptor (A3AR) agonist, improved liver
function/pathology in non‐alcoholic steatohepatitis (NASH) preclinical models. Aim To evaluate …
function/pathology in non‐alcoholic steatohepatitis (NASH) preclinical models. Aim To evaluate …
